StonvexLoading…
StonvexStonvexStonvexCore line items from AVB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.04M | $7.08M | $7.72M | $6.33M |
Operating Income | $2.02B | $1.91B | $1.79B | $1.70B |
Net Income | $1.06B | $1.08B | $928.83M | $1.14B |
EPS (Diluted) | $7.40 | $7.60 | $6.56 | $8.12 |
Total Assets | $22.19B | $21.00B | $20.68B | $20.46B |
Total Liabilities | $10.36B | $9.06B | $8.89B | $9.20B |
Cash & Equivalents | $187.23M | $108.58M | $397.89M | $613.19M |
Free Cash Flow OCF − CapEx | $1.41B | $1.41B | $1.38B | $1.26B |
Shares Outstanding | 140.08M | 142.25M | 142.03M | 139.92M |